Association Between TTV Infection and Abnormal ALT in the Studied Groups
| . | TTV DNA+ (N = 19/250) . | TTV DNA+ HCVAb− (N = 7/148) . |
|---|---|---|
| Blood donors | ||
| ALT normal | 4/114 | 4/114 |
| ALT abnormal | 0/3 | 0/3 |
| Patients with coagulopathy | ||
| ALT normal | 2/25 | 0/4 |
| ALT abnormal | 2/9 | 0/0 |
| Intravenous drug users | ||
| ALT normal | 4/38 | 2/12 |
| ALT abnormal | 1/12 | 0/0 |
| Chronic liver disease | ||
| ALT normal | 1/24 | 1/13 |
| ALT abnormal | 5/25 | 0/2 |
| Total | ||
| ALT normal | 11/201 | 7/143 |
| ALT abnormal | 8/49 | 0/5 |
| . | TTV DNA+ (N = 19/250) . | TTV DNA+ HCVAb− (N = 7/148) . |
|---|---|---|
| Blood donors | ||
| ALT normal | 4/114 | 4/114 |
| ALT abnormal | 0/3 | 0/3 |
| Patients with coagulopathy | ||
| ALT normal | 2/25 | 0/4 |
| ALT abnormal | 2/9 | 0/0 |
| Intravenous drug users | ||
| ALT normal | 4/38 | 2/12 |
| ALT abnormal | 1/12 | 0/0 |
| Chronic liver disease | ||
| ALT normal | 1/24 | 1/13 |
| ALT abnormal | 5/25 | 0/2 |
| Total | ||
| ALT normal | 11/201 | 7/143 |
| ALT abnormal | 8/49 | 0/5 |
Abnormal: >1.5 the upper limit of reference range.